- Home
- / DexTech Medical
DexTech Medical
Stock Price
$7.6
2023-03-10
Market Capitalization
$80.3 M
2023-03-10
DexTech Medical Summary
Company Summary
- Overview
- DexTech Medical is a research company specializing in urological oncology. The company develops medications based on a modified carbon hydrate molecule combined with active substances, including generics. Its candidate, OsteoDex, is designed for the treatment of skeletal metastases in castration-resistant prostate cancer.
- Type
- Public
- Status
- Active
- Founded
- 2004
- HQ
- Uppsala, SE | view all locations
- Website
- https://dextechmedical.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Uppsala, Uppsala län HQ
Sweden
Uppsala Science Park, Dag Hammarskjölds Väg 36
DexTech Medical Financials
Summary Financials
- Net income (Q3, 2026)
- (kr1.7M)
- Cash (Q3, 2026)
- kr10.1M
- EBIT (Q3, 2026)
- (kr1.7M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026